| PRD_000453 | Name: | N-[3-(1H-benzimidazol-1-yl)propanoyl]glycyl-L-alanyl-L-alaninamide | Formula: | C18 H24 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000457 | Name: | INHIBITOR CH2-QLTSNV-Z (SUBSTRATE-ANALOG) | Formula: | C36 H55 Cl N8 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000480 | Name: | DECAPEPTIDE HIRUDIN ANALOGUE | Formula: | C68 H95 N11 O26 S | Description: | DECAPEPTIDE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000481 | Name: | N-terminal Asp des-amino Hirudin-3A' | Formula: | C64 H89 N11 O24 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000483 | Name: | Bacillomycin Lc | Formula: | C47 H74 N10 O16 | Description: | BACILLOMYCIN LC IS A CYCLIC HEPTA-LIPOPETIDE
WITH 7 AMINO-ACIDS OF CONFIGURATION LDDLLDL AND
ONE D-BETA-AMINO CARBOXYLIC ACID.
THE FATTY ACID IS LINKED VIA A PEPTID BOND
TO BOTH RESIDUES 2 AND 8. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000487 | Name: | Tsushimycin | Formula: | C59 H93 N13 O20 | Description: | TSUSHIMYCIN IS A CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) ASP1 N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE RING. RESIDUE 2 AND 11 FORM
A PEPTIDE BOND.
A TETRADECENOIC FATTY ACID IS LINKED TO THE
RESIDUE 1 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000488 | Name: | TRIOSTIN A | Formula: | C50 H62 N12 O12 S2 | Description: | TRIOSTIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A DISULPHIDE BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000491 | Name: | Echinomycin | Formula: | C51 H64 N12 O12 S2 | Description: | ECHINOMYCIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000492 | Name: | uk63052 | Formula: | C56 H68 N10 O14 S2 | Description: | QUINOMYCIN UK63052 IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO HYDROXYQUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000504 | Name: | ADEP2 | Formula: | C41 H56 F2 N6 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000507 | Name: | PYOVERDIN C-E CHROMOPHORE | Formula: | C55 H86 N17 O22 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS AERUGINOSA SECRETES A MAJOR FLUORESCENT SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR FPVA. FPVA IS A
TONB-DEPENDENT TRANSPORT PROTEIN AND HAS THE ABILITY TO BIND PVD IN ITS APO- OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000556 | Name: | AERUGINOSIN 98-B | Formula: | C29 H46 N6 O9 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000557 | Name: | Pepstatin | Formula: | C34 H63 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000558 | Name: | Chymostatin A | Formula: | C31 H41 N7 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000559 | Name: | Chymostatin | Formula: | C22 H32 N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000563 | Name: | N-[(2R)-1-{[(2S,3R,5R)-1-cyclohexyl-3-hydroxy-5-{[2-(morpholin-4-yl)ethyl]carbamoyl}oct-7-yn-2-yl]amino}-3-(methylsulfa
nyl)-1-oxopropan-2-yl]-1H-benzimidazole-2-carboxamide | Formula: | C33 H48 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000565 | Name: | N-[(2S)-1-[[(2S)-1-[[(2S,3R)-1-cyclohexyl-4,4-difluoro-3-hydroxy-5-(methylamino)-5-oxo-pentan-2-yl]amino]-1-oxo-hexan-2
-yl]amino]-1-oxo-3-phenyl-propan-2-yl]morpholine-4-carboxamide | Formula: | C32 H49 F2 N5 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000568 | Name: | N-[(benzyloxy)carbonyl]-3-[(2,2-dimethylpropanoyl)amino]-L-alanyl-N-[(1R)-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}pentyl]-L-leucinamide | Formula: | C32 H49 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000597 | Name: | N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide | Formula: | C22 H26 N4 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000606 | Name: | (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide | Formula: | C21 H30 N4 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000607 | Name: | (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide | Formula: | C22 H32 N4 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000616 | Name: | 3-cyclohexyl-D-alanyl-L-prolyl-N~2~-methyl-L-arginine | Formula: | C21 H38 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000657 | Name: | methyl N-[(2S)-2-({(S)-hydroxy[(1R)-3-methyl-1-{[N-(3-methylbutanoyl)-L-valyl-L-valyl]amino}butyl]phosphoryl}oxy)-3-phenylpropanoyl]-L-alanyl-L-alaninate | Formula: | C36 H60 N5 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000668 | Name: | N~2~-{(2S)-3-[(R)-hydroxy{(1R)-2-phenyl-1-[(phenylacetyl)amino]ethyl}phosphoryl]-2-methylpropanoyl}-L-lysyl-D-serine | Formula: | C29 H41 N4 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000669 | Name: | 1-{3-[(R)-{(1R)-1-[(glycyl-L-prolyl)amino]-2-phenylethyl}(hydroxy)phosphoryl]propanoyl}-L-prolyl-D-norleucine | Formula: | C29 H44 N5 O8 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|